Skip to main content
. 2017 Aug 16;35(35Part B):4561–4568. doi: 10.1016/j.vaccine.2017.07.019

Supplementary Fig. 2.

Supplementary Fig. 2

Observed and predicted carriage prevalence over time, under constant population. Observed (circular dots with 95% credible intervals shown by spikes) and predicted (lines with 95% predictive intervals shown by shaded areas) carriage prevalence of VT (red), strong NVT (blue) and weak NVT (lime green) over time since vaccine introduction. The age groups are labelled at the panel titles.